Clinical Trial

Effect of Lactobacillus Johnsonii or White Pomegranate Extract on the Vaginal Health

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 14, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this clinical trial is to explore the effect of Lactobacillus johnsonii and white pomegranate extract on female bacterial status, it aims to answer are: * Evaluate Lactobacillus johnsonii TCI250 probiotics or white pomegranate extract in regulating female vaginal bacteria and improving vaginal health. * Evaluate Lactobacillus johnsonii TCI250 probiotics or white pomegranate extract in regulating inflammation. Participants will be randomly assigned to placebo (n = 50), probiotic heat-killed Lactobacillus johnsonii TCI250 group (n = 50) and white pomegranate extract group (n = 50) for 8 weeks. Researchers will compare the vaginal flora and inflammation.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2023-10-02; most recent amendment 2025-05-12.
Status change: Not Yet Recruiting → Recruiting 2023-10-19
Trial Details
NCT Number NCT06069531
Lead Sponsor Chung Shan Medical University
Collaborators: TCI Co., Ltd.
Conditions Vaginitis Bacterial, Inflammation, Ear
Enrollment 150 participants
Start Date 2022-04-04
Primary Completion 2025-12-31 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-05-14